Labcyte Inc. And FIMM Extend Collaboration To Bring Real-Time Personalized Medicine To Cancer Treatments
SUNNYVALE, Calif. & HELSINKI--(BUSINESS WIRE)--Labcyte Inc. and the Institute for Molecular Medicine Finland (FIMM) of the University of Helsinki, announced today the extension of a collaboration that began in 2013 centering on the use of Labcyte’s Echo® liquid handlers for new personalized medicine strategies to treat cancer patients.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.